Tekla Capital Management as of Dec. 31, 2016
Portfolio Holdings for Tekla Capital Management
Tekla Capital Management holds 143 positions in its portfolio as reported in the December 2016 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Gilead Sciences (GILD) | 7.7 | $181M | 2.5M | 71.61 | |
Celgene Corporation | 7.0 | $163M | 1.4M | 115.75 | |
Biogen Idec (BIIB) | 6.5 | $152M | 537k | 283.58 | |
Alexion Pharmaceuticals | 4.2 | $97M | 796k | 122.35 | |
Allergan | 3.9 | $91M | 434k | 210.01 | |
Incyte Corporation (INCY) | 3.8 | $88M | 881k | 100.27 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 3.2 | $76M | 1.0M | 73.67 | |
Merck & Co (MRK) | 3.0 | $71M | 1.2M | 58.87 | |
Regeneron Pharmaceuticals (REGN) | 2.9 | $69M | 188k | 367.09 | |
Abbott Laboratories (ABT) | 2.6 | $61M | 1.6M | 38.41 | |
Johnson & Johnson (JNJ) | 2.2 | $51M | 443k | 115.21 | |
BioMarin Pharmaceutical (BMRN) | 2.0 | $47M | 573k | 82.84 | |
Amgen (AMGN) | 2.0 | $47M | 322k | 146.21 | |
Medtronic (MDT) | 1.9 | $44M | 623k | 71.23 | |
Mylan Nv | 1.9 | $43M | 1.1M | 38.15 | |
UnitedHealth (UNH) | 1.7 | $39M | 246k | 160.04 | |
Shire | 1.7 | $39M | 231k | 170.38 | |
Pfizer (PFE) | 1.6 | $37M | 1.1M | 32.48 | |
Eli Lilly & Co. (LLY) | 1.5 | $36M | 493k | 73.55 | |
Jazz Pharmaceuticals (JAZZ) | 1.5 | $36M | 331k | 109.03 | |
Humana (HUM) | 1.4 | $34M | 165k | 204.03 | |
CVS Caremark Corporation (CVS) | 1.4 | $33M | 412k | 78.91 | |
Illumina (ILMN) | 1.3 | $32M | 247k | 128.04 | |
Teva Pharmaceutical Industries (TEVA) | 1.2 | $29M | 789k | 36.25 | |
Medicines Company | 1.1 | $26M | 772k | 33.94 | |
AmerisourceBergen (COR) | 1.1 | $26M | 331k | 78.19 | |
Centene Corporation (CNC) | 1.0 | $23M | 400k | 56.51 | |
Molina Healthcare (MOH) | 0.9 | $22M | 403k | 54.26 | |
Thermo Fisher Scientific (TMO) | 0.8 | $20M | 141k | 141.10 | |
Novartis (NVS) | 0.8 | $18M | 249k | 72.84 | |
Universal Health Services (UHS) | 0.7 | $16M | 147k | 106.38 | |
IDEXX Laboratories (IDXX) | 0.7 | $16M | 132k | 117.27 | |
iShares NASDAQ Biotechnology Index (IBB) | 0.7 | $15M | 58k | 265.37 | |
Neurocrine Biosciences (NBIX) | 0.7 | $15M | 392k | 38.70 | |
Endo International | 0.6 | $15M | 915k | 16.47 | |
Omega Healthcare Investors (OHI) | 0.6 | $14M | 459k | 31.26 | |
Hca Holdings (HCA) | 0.6 | $14M | 190k | 74.02 | |
GlaxoSmithKline | 0.6 | $14M | 359k | 38.51 | |
United Therapeutics Corporation (UTHR) | 0.6 | $13M | 93k | 143.43 | |
Sabra Health Care REIT (SBRA) | 0.6 | $14M | 551k | 24.42 | |
AstraZeneca (AZN) | 0.5 | $13M | 464k | 27.32 | |
Sarepta Therapeutics (SRPT) | 0.5 | $13M | 466k | 27.43 | |
Sanofi-Aventis SA (SNY) | 0.5 | $12M | 305k | 40.44 | |
Medical Properties Trust (MPW) | 0.5 | $12M | 1.0M | 12.30 | |
Senior Housing Properties Trust | 0.5 | $12M | 647k | 18.93 | |
Welltower Inc 6.50% pfd prepet | 0.5 | $12M | 200k | 60.18 | |
Paratek Pharmaceuticals | 0.5 | $12M | 763k | 15.40 | |
CIGNA Corporation | 0.5 | $12M | 86k | 133.39 | |
Cardinal Health (CAH) | 0.5 | $11M | 153k | 71.97 | |
Ventas (VTR) | 0.5 | $11M | 176k | 62.52 | |
Zimmer Holdings (ZBH) | 0.5 | $11M | 102k | 103.20 | |
SPDR S&P Biotech (XBI) | 0.5 | $11M | 179k | 59.19 | |
Becton, Dickinson and (BDX) | 0.4 | $10M | 63k | 165.56 | |
Foamix Pharmaceuticals | 0.4 | $10M | 930k | 11.10 | |
Natera (NTRA) | 0.4 | $10M | 882k | 11.71 | |
Physicians Realty Trust | 0.4 | $10M | 531k | 18.96 | |
Merus N V (MRUS) | 0.4 | $10M | 479k | 21.11 | |
Charles River Laboratories (CRL) | 0.4 | $9.7M | 128k | 76.19 | |
Alnylam Pharmaceuticals (ALNY) | 0.4 | $9.1M | 244k | 37.44 | |
Ardelyx (ARDX) | 0.4 | $9.1M | 639k | 14.20 | |
Aegerion Pharmaceuticals 2% Du cvbond | 0.4 | $9.2M | 13M | 0.71 | |
Care Cap Properties | 0.4 | $8.6M | 345k | 25.00 | |
Exelixis (EXEL) | 0.3 | $8.2M | 552k | 14.91 | |
Cytomx Therapeutics (CTMX) | 0.3 | $8.3M | 756k | 10.99 | |
Puma Biotechnology (PBYI) | 0.3 | $8.0M | 260k | 30.70 | |
Galapagos Nv- (GLPG) | 0.3 | $7.4M | 116k | 64.19 | |
Akorn | 0.3 | $7.2M | 328k | 21.83 | |
Flamel Technologies | 0.3 | $6.5M | 624k | 10.39 | |
LTC Properties (LTC) | 0.3 | $6.4M | 136k | 46.98 | |
Ultragenyx Pharmaceutical (RARE) | 0.3 | $6.2M | 88k | 70.31 | |
Egalet Corporation note 5.50% 4/1/20 | 0.3 | $6.1M | 7.0M | 0.87 | |
Pieris Pharmaceuticals | 0.2 | $5.8M | 4.1M | 1.40 | |
New Senior Inv Grp | 0.2 | $5.6M | 568k | 9.79 | |
Pra Health Sciences | 0.2 | $5.6M | 102k | 55.12 | |
Icon (ICLR) | 0.2 | $5.4M | 72k | 75.19 | |
Xenon Pharmaceuticals (XENE) | 0.2 | $5.4M | 700k | 7.70 | |
Global Blood Therapeutics In | 0.2 | $5.5M | 381k | 14.45 | |
Cellectis S A (CLLS) | 0.2 | $5.3M | 310k | 16.95 | |
Epizyme | 0.2 | $4.8M | 400k | 12.10 | |
Dermira | 0.2 | $5.0M | 165k | 30.33 | |
Myovant Sciences | 0.2 | $5.0M | 400k | 12.44 | |
Momenta Pharmaceuticals | 0.2 | $4.6M | 307k | 15.05 | |
Karyopharm Therapeutics (KPTI) | 0.2 | $4.7M | 500k | 9.40 | |
Immunomedics Inc note 4.750% 2/1 | 0.2 | $4.0M | 4.0M | 0.99 | |
Allergan Plc pfd conv ser a | 0.2 | $3.8M | 5.0k | 762.40 | |
Beigene | 0.1 | $3.5M | 117k | 30.36 | |
ACADIA Pharmaceuticals (ACAD) | 0.1 | $3.2M | 112k | 28.84 | |
Retrophin | 0.1 | $3.2M | 168k | 18.93 | |
Mallinckrodt Pub | 0.1 | $3.1M | 62k | 49.82 | |
Bluebird Bio (BLUE) | 0.1 | $3.0M | 49k | 61.71 | |
Perrigo Company (PRGO) | 0.1 | $3.1M | 37k | 83.22 | |
Valeant Pharmaceuticals Int | 0.1 | $2.8M | 192k | 14.52 | |
Sage Therapeutics (SAGE) | 0.1 | $2.8M | 54k | 51.06 | |
Grifols S A Sponsored Adr R (GRFS) | 0.1 | $2.7M | 166k | 16.07 | |
Accelr8 Technology | 0.1 | $2.5M | 120k | 20.75 | |
Horizon Pharma | 0.1 | $2.6M | 163k | 16.18 | |
Coherus Biosciences (CHRS) | 0.1 | $2.5M | 90k | 28.16 | |
Tenet Healthcare Corporation (THC) | 0.1 | $2.4M | 165k | 14.84 | |
Dbv Technologies S A | 0.1 | $2.3M | 66k | 35.14 | |
Adaptimmune Therapeutics (ADAP) | 0.1 | $2.3M | 566k | 4.05 | |
Arca Biopharma | 0.1 | $2.3M | 811k | 2.85 | |
Healthcare Realty Trust Incorporated | 0.1 | $2.1M | 68k | 30.32 | |
McKesson Corporation (MCK) | 0.1 | $2.1M | 15k | 140.47 | |
Amicus Therapeutics (FOLD) | 0.1 | $2.1M | 419k | 4.97 | |
Endologix | 0.1 | $2.2M | 387k | 5.72 | |
Acadia Healthcare (ACHC) | 0.1 | $2.1M | 65k | 33.10 | |
Adamas Pharmaceuticals | 0.1 | $2.1M | 126k | 16.90 | |
Forward Pharma A/s | 0.1 | $2.0M | 137k | 15.01 | |
Nabriva Therapeutics | 0.1 | $2.1M | 350k | 5.95 | |
Allscripts Healthcare Solutions (MDRX) | 0.1 | $1.8M | 174k | 10.21 | |
Halozyme Therapeutics (HALO) | 0.1 | $2.0M | 200k | 9.88 | |
Achillion Pharmaceuticals | 0.1 | $1.8M | 444k | 4.13 | |
Impax Laboratories | 0.1 | $1.6M | 124k | 13.25 | |
Diplomat Pharmacy | 0.1 | $1.6M | 130k | 12.60 | |
HCP | 0.1 | $1.4M | 46k | 29.71 | |
Chimerix (CMRX) | 0.1 | $1.4M | 309k | 4.60 | |
Acceleron Pharma | 0.1 | $1.4M | 55k | 25.53 | |
Uniqure Nv (QURE) | 0.1 | $1.3M | 241k | 5.60 | |
Dynavax Technologies (DVAX) | 0.1 | $1.4M | 345k | 3.95 | |
Healthcare Tr Amer Inc cl a | 0.1 | $1.3M | 46k | 29.11 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.1 | $1.4M | 133k | 10.40 | |
Welltower Inc Com reit (WELL) | 0.1 | $1.4M | 21k | 66.92 | |
Community Health Systems (CYH) | 0.1 | $1.1M | 204k | 5.59 | |
GenMark Diagnostics | 0.1 | $1.1M | 93k | 12.24 | |
Esperion Therapeutics (ESPR) | 0.1 | $1.3M | 103k | 12.52 | |
Therapeuticsmd | 0.1 | $1.1M | 187k | 5.77 | |
Juno Therapeutics | 0.1 | $1.1M | 57k | 18.86 | |
Spark Therapeutics | 0.1 | $1.2M | 24k | 49.92 | |
Alliqua | 0.0 | $974k | 1.7M | 0.59 | |
Auris Med Hldg | 0.0 | $829k | 775k | 1.07 | |
Flex Pharma | 0.0 | $856k | 162k | 5.28 | |
Intellia Therapeutics (NTLA) | 0.0 | $942k | 72k | 13.11 | |
Novavax | 0.0 | $720k | 571k | 1.26 | |
Tetraphase Pharmaceuticals | 0.0 | $775k | 192k | 4.03 | |
Bellicum Pharma | 0.0 | $817k | 60k | 13.62 | |
Global Medical Reit (GMRE) | 0.0 | $655k | 73k | 8.92 | |
Celldex Therapeutics | 0.0 | $375k | 106k | 3.54 | |
Xencor (XNCR) | 0.0 | $526k | 20k | 26.30 | |
Affimed Therapeutics B V | 0.0 | $530k | 294k | 1.80 | |
Rmr Group Inc cl a (RMR) | 0.0 | $294k | 7.4k | 39.51 | |
Quorum Health | 0.0 | $172k | 24k | 7.25 | |
Abbvie (ABBV) | 0.0 | $10k | 156.00 | 64.10 | |
Zafgen | 0.0 | $42k | 13k | 3.16 |